首页 > 最新文献

JTCVS open最新文献

英文 中文
Significant reduction in blood product usage, same early outcomes: Blood conservation in infants undergoing open heart surgery. 血液制品使用显著减少,早期结果相同:接受心脏直视手术的婴儿血液保存。
Pub Date : 2024-10-11 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.006
Lyubomyr Bohuta, Titus Chan, Kevin Charette, Gregory Latham, Christina L Greene, David Mauchley, Andrew Koth, D Michael McMullan

Objective: To evaluate the effect of a blood conservation program on trends in use of donor blood products and early clinical outcomes in infants undergoing open heart surgery.

Methods: Four hundred nine patients younger than age 1 year undergoing open-heart surgery between October 1, 2020, and June 30, 2023, were reviewed. The study period was divided into 4 eras with the first era as a before blood conservation baseline using traditional blood management. The following 3 eras comprised incremental implementation and evolution of blood conservation strategies. The total volume of blood products transfused for each surgical hospitalization was calculated and indexed to body weight at time of surgery.

Results: There was no significant difference in age at surgery, body weight, distribution of The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery categories, and in postoperative length of mechanical ventilation, intensive care unit or hospital length of stay, or postoperative mortality (P > .05 for all) across the 4 eras. Median total volume of blood products administered during hospitalization decreased from 128 mL/kg (range, 92-220 mL/kg) during the baseline period to 21 mL/kg (range, 6-44 mL/kg) during the last era (P < .01). Multivariate analysis demonstrated that later eras were associated with decreased odds of experiencing exposure to blood products during hospitalization.

Conclusions: Blood conservation is associated with significant reduction in usage of blood products during open heart surgery in infants with no significant effect on early outcomes. This trend is observed across all categories of surgical complexity. Additional studies are needed to prove consistency and to determine the longer-term clinical impact of this strategy.

目的:评估血液保护计划对接受心脏直视手术的婴儿供体血液制品使用趋势和早期临床结果的影响。方法:对2020年10月1日至2023年6月30日期间接受心脏直视手术的490例年龄小于1岁的患者进行回顾性分析。研究期分为4个时期,第一个时期为采用传统血液管理前的血液保护基线。接下来的3个时代包括血液保护策略的逐步实施和演变。计算每次手术住院的输血总量,并以手术时的体重为指标。结果:手术年龄、体重、胸外科学会-欧洲心胸外科协会分类分布、术后机械通气时间、重症监护病房或住院时间、术后死亡率在4个时代均无显著差异(P < 0.05)。住院期间使用的血液制品中位数总容量从基线期的128 mL/kg(范围,92-220 mL/kg)降至上一个时期的21 mL/kg(范围,6-44 mL/kg) (P结论:血液保存与婴儿心脏手术期间血液制品使用量的显著减少有关,但对早期结局没有显著影响。这一趋势在所有类型的复杂手术中都可以观察到。需要进一步的研究来证明一致性并确定该策略的长期临床影响。
{"title":"Significant reduction in blood product usage, same early outcomes: Blood conservation in infants undergoing open heart surgery.","authors":"Lyubomyr Bohuta, Titus Chan, Kevin Charette, Gregory Latham, Christina L Greene, David Mauchley, Andrew Koth, D Michael McMullan","doi":"10.1016/j.xjon.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.10.006","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effect of a blood conservation program on trends in use of donor blood products and early clinical outcomes in infants undergoing open heart surgery.</p><p><strong>Methods: </strong>Four hundred nine patients younger than age 1 year undergoing open-heart surgery between October 1, 2020, and June 30, 2023, were reviewed. The study period was divided into 4 eras with the first era as a before blood conservation baseline using traditional blood management. The following 3 eras comprised incremental implementation and evolution of blood conservation strategies. The total volume of blood products transfused for each surgical hospitalization was calculated and indexed to body weight at time of surgery.</p><p><strong>Results: </strong>There was no significant difference in age at surgery, body weight, distribution of The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery categories, and in postoperative length of mechanical ventilation, intensive care unit or hospital length of stay, or postoperative mortality (<i>P</i> > .05 for all) across the 4 eras. Median total volume of blood products administered during hospitalization decreased from 128 mL/kg (range, 92-220 mL/kg) during the baseline period to 21 mL/kg (range, 6-44 mL/kg) during the last era (<i>P</i> < .01). Multivariate analysis demonstrated that later eras were associated with decreased odds of experiencing exposure to blood products during hospitalization.</p><p><strong>Conclusions: </strong>Blood conservation is associated with significant reduction in usage of blood products during open heart surgery in infants with no significant effect on early outcomes. This trend is observed across all categories of surgical complexity. Additional studies are needed to prove consistency and to determine the longer-term clinical impact of this strategy.</p>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"450-457"},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interatrial block is an independent risk factor for new-onset atrial fibrillation after cardiac surgery. 心房传导阻滞是心脏手术后新发心房颤动的独立危险因素。
Pub Date : 2024-10-10 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.003
Spela Leiler, Andre Bauer, Wolfgang Hitzl, Rok Bernik, Valentin Guenzler, Matthias Angerer, Theodor Fischlein, Jurij Matija Kalisnik

Objectives: This study aims to investigate the association between interatrial conduction block and postoperative atrial fibrillation, which can precipitate acute cardiopulmonary instability and is associated with subsequent heart failure, stroke, and mortality following cardiac surgery.

Methods: Perioperative 12-channel electrocardiograms from 3405 patients undergoing myocardial revascularization, valve surgery, aortic surgery, or combinations thereof, were considered. Clinical and electrographic parameters were compared between patients with and without atrial fibrillation, and significant variables were analyzed using univariate and multivariate logistic regression.

Results: Among 2108 analyzed patients, 764 (36.2%) developed atrial fibrillation. Preoperative interatrial block was a strong independent risk factor (3.18; 95% CI, 2.55, 3.96; P < .001), significantly improving area under the receiver operator characteristics curve from 71.8% to 75.6% (Delong's test: P = .013). Other risk factors included advanced age (1.05; 95% CI, 1.03, 1.07; P < .001), female gender (1.86; 95% CI, 1.45, 2.38; P < .001), history of cardiogenic shock (1.44; 95% CI, 0.99, 2.09; P = .057), reduced left ventricular ejection fraction <40% (1.57; 95% CI, 1.06, 2.33; P = .024), cessation of preoperative β-blockers (1.17; 95% CI, 0.95, 1.46; P = .145), score for clinical prediction rules for estimating the risk of stroke in people with non-rheumatic atrial fibrillation (CHAS2DS2-VASc) and European System for Cardiac Operative Risk Evaluation II score (0.87; 95% CI, 0.79, 0.97; P = .01) and (1.04; 95% CI, 0.99, 1.11; P = .138), preexisting left bundle branch block (1.59; 95% CI, 0.92, 2.74; P = .097), cardiopulmonary bypass time (1.00; 95% CI, 1.00, 1.00; P = .049), bicaval cannulation (1.45; 95% CI, 0.88, 2.41; P = .035), cardiac surgery-associated acute kidney injury (3.19; 95% CI, 2.45, 4.15; P < .001), and postoperative atrioventricular block (1.20; 95% CI, 0.96, 1.51; P = .105), particularly Mobitz I (6.73; 95% CI, 1.98, 31.51; P = .005).

Conclusions: Perioperative electrocardiogram-derived parameters, especially interatrial block, are associated with postoperative atrial fibrillation. Further research is needed to clarify the link between conduction abnormalities and postoperative atrial fibrillation, enabling targeted prophylactic therapies for high-risk patients.

目的:本研究旨在探讨心房传导阻滞与术后心房颤动之间的关系,心房颤动可诱发急性心肺不稳定,并与心脏手术后的心力衰竭、中风和死亡率相关。方法:分析3405例接受心肌血运重建术、瓣膜手术、主动脉手术或两者联合手术的患者围术期12通道心电图。比较心房颤动患者和非心房颤动患者的临床和电图参数,并采用单因素和多因素logistic回归分析显著变量。结果:在分析的2108例患者中,764例(36.2%)发生心房颤动。术前房间传导阻滞是较强的独立危险因素(3.18;95% ci, 2.55, 3.96;p = .013)。其他危险因素包括高龄(1.05;95% ci, 1.03, 1.07;P P = 0.057),左室射血分数降低P = 0.024),术前停止β受体阻滞剂(1.17;95% ci, 0.95, 1.46;P = 0.145)、非风湿性房颤患者卒中风险的临床预测规则评分(CHAS2DS2-VASc)和欧洲心脏手术风险评估系统II评分(0.87;95% ci, 0.79, 0.97;P = 0.01)和(1.04);95% ci, 0.99, 1.11;P = .138),先前存在的左束支阻滞(1.59;95% ci, 0.92, 2.74;P = 0.097),体外循环时间(1.00;95% ci, 1.00, 1.00;P = 0.049),双腔插管(1.45;95% ci, 0.88, 2.41;P = 0.035),心脏手术相关急性肾损伤(3.19;95% ci, 2.45, 4.15;P = .105),尤其是Mobitz I (6.73;95% ci, 1.98, 31.51;p = .005)。结论:围手术期心电图衍生参数,尤其是心房传导阻滞,与术后心房颤动有关。需要进一步的研究来阐明传导异常与术后房颤之间的联系,从而为高危患者提供有针对性的预防性治疗。
{"title":"Interatrial block is an independent risk factor for new-onset atrial fibrillation after cardiac surgery.","authors":"Spela Leiler, Andre Bauer, Wolfgang Hitzl, Rok Bernik, Valentin Guenzler, Matthias Angerer, Theodor Fischlein, Jurij Matija Kalisnik","doi":"10.1016/j.xjon.2024.10.003","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.10.003","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to investigate the association between interatrial conduction block and postoperative atrial fibrillation, which can precipitate acute cardiopulmonary instability and is associated with subsequent heart failure, stroke, and mortality following cardiac surgery.</p><p><strong>Methods: </strong>Perioperative 12-channel electrocardiograms from 3405 patients undergoing myocardial revascularization, valve surgery, aortic surgery, or combinations thereof, were considered. Clinical and electrographic parameters were compared between patients with and without atrial fibrillation, and significant variables were analyzed using univariate and multivariate logistic regression.</p><p><strong>Results: </strong>Among 2108 analyzed patients, 764 (36.2%) developed atrial fibrillation. Preoperative interatrial block was a strong independent risk factor (3.18; 95% CI, 2.55, 3.96; <i>P</i> < .001), significantly improving area under the receiver operator characteristics curve from 71.8% to 75.6% (Delong's test: <i>P</i> = .013). Other risk factors included advanced age (1.05; 95% CI, 1.03, 1.07; <i>P</i> < .001), female gender (1.86; 95% CI, 1.45, 2.38; <i>P</i> < .001), history of cardiogenic shock (1.44; 95% CI, 0.99, 2.09; <i>P</i> = .057), reduced left ventricular ejection fraction <40% (1.57; 95% CI, 1.06, 2.33; <i>P</i> = .024), cessation of preoperative β-blockers (1.17; 95% CI, 0.95, 1.46; <i>P</i> = .145), score for clinical prediction rules for estimating the risk of stroke in people with non-rheumatic atrial fibrillation (CHAS<sub>2</sub>DS<sub>2</sub>-VASc) and European System for Cardiac Operative Risk Evaluation II score (0.87; 95% CI, 0.79, 0.97; <i>P</i> = .01) and (1.04; 95% CI, 0.99, 1.11; <i>P</i> = .138), preexisting left bundle branch block (1.59; 95% CI, 0.92, 2.74; <i>P</i> = .097), cardiopulmonary bypass time (1.00; 95% CI, 1.00, 1.00; <i>P</i> = .049), bicaval cannulation (1.45; 95% CI, 0.88, 2.41; <i>P</i> = .035), cardiac surgery-associated acute kidney injury (3.19; 95% CI, 2.45, 4.15; <i>P</i> < .001), and postoperative atrioventricular block (1.20; 95% CI, 0.96, 1.51; <i>P</i> = .105), particularly Mobitz I (6.73; 95% CI, 1.98, 31.51; <i>P</i> = .005).</p><p><strong>Conclusions: </strong>Perioperative electrocardiogram-derived parameters, especially interatrial block, are associated with postoperative atrial fibrillation. Further research is needed to clarify the link between conduction abnormalities and postoperative atrial fibrillation, enabling targeted prophylactic therapies for high-risk patients.</p>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"345-353"},"PeriodicalIF":0.0,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentator Discussion: Combined simulation and ex-vivo assessment of free-edge length in bicuspidization repair for congenital aortic valve disease. 解说员讨论:先天性主动脉瓣疾病双尖修复术中自由边缘长度的联合模拟和离体评估。
Pub Date : 2024-10-10 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.005
{"title":"Commentator Discussion: Combined simulation and ex-vivo assessment of free-edge length in bicuspidization repair for congenital aortic valve disease.","authors":"","doi":"10.1016/j.xjon.2024.10.005","DOIUrl":"10.1016/j.xjon.2024.10.005","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"405-406"},"PeriodicalIF":0.0,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning-derived multivariable predictors of postcardiotomy cardiogenic shock in high-risk cardiac surgery patients. 高危心脏手术患者心源性休克的机器学习衍生多变量预测因子。
Pub Date : 2024-10-09 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.002
Edward G Soltesz, Randi J Parks, Elise M Jortberg, Eugene H Blackstone

Objective: To develop a model for preoperatively predicting postcardiotomy cardiogenic shock (PCCS) in patients with poor left ventricular (LV) function undergoing cardiac surgery.

Methods: From the Society of Thoracic Surgeons Adult Cardiac Database, 11,493 patients with LV ejection fraction ≤35% underwent isolated on-pump surgery from 2018 through 2019, of whom 3428 experienced PCCS. In total, 68 preoperative clinical variables were considered in machine-learning algorithms trained and optimized using scikit-learn software.

Results: Compared with patients with ideal recovery, those that did were younger (65 vs 67 years), more likely female, Black, with low LV ejection fraction (26.5 vs 28.9%), previous myocardial infarction, chronic lung disease, diabetes, reoperation, or advanced heart failure. Among those with PCCS versus ideal recovery, operative mortality was 27% (925/3428) versus 0.1% (5/8065). PCCS occurred more often after coronary artery bypass grafting with concomitant mitral valve repair or after longer perfusion and clamp times. Reliable preoperative PCCS predictors were more advanced cardiac, liver, and renal failure; frailty; and greater white cell count. Out of sample test set receiver operating curve achieved an area under the curve of 0.74 with acceptable calibration Hosmer-Lemeshow statistic χ2 = 1.33, P = .25.

Conclusions: In patients with severe LV dysfunction undergoing cardiac surgery, risk of PCCS is elevated by preoperative failure of other organ systems and complexity of the planned operation that prolongs myocardial ischemia and cardiopulmonary bypass. This risk calculator could serve as an important tool to preoperatively identify patients in need of advanced levels of support.

目的:建立心脏手术左室功能差患者开心术后心源性休克(PCCS)的术前预测模型。方法:从胸外科学会成人心脏数据库中,2018年至2019年,11,493例左室射血分数≤35%的患者接受了孤立的无泵手术,其中3428例经历了PCCS。在使用scikit-learn软件训练和优化的机器学习算法中,总共考虑了68个术前临床变量。结果:与恢复理想的患者相比,恢复理想的患者更年轻(65岁vs 67岁),更可能是女性,黑人,低左室射血分数(26.5 vs 28.9%),既往心肌梗死,慢性肺病,糖尿病,再手术或晚期心力衰竭。在PCCS患者和理想恢复患者中,手术死亡率分别为27%(925/3428)和0.1%(5/8065)。冠状动脉旁路移植术合并二尖瓣修复或较长的灌注和夹持时间后发生PCCS较多。可靠的术前PCCS预测指标是更晚期的心脏、肝脏和肾功能衰竭;脆弱;白细胞数量增加。样本外测试集接收者工作曲线的曲线下面积为0.74,可接受校准Hosmer-Lemeshow统计量χ2 = 1.33, P = 0.25。结论:在接受心脏手术的严重左室功能障碍患者中,术前其他器官系统衰竭和计划手术的复杂性延长了心肌缺血和体外循环,增加了PCCS的风险。这种风险计算器可以作为术前识别需要高级支持的患者的重要工具。
{"title":"Machine learning-derived multivariable predictors of postcardiotomy cardiogenic shock in high-risk cardiac surgery patients.","authors":"Edward G Soltesz, Randi J Parks, Elise M Jortberg, Eugene H Blackstone","doi":"10.1016/j.xjon.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.10.002","url":null,"abstract":"<p><strong>Objective: </strong>To develop a model for preoperatively predicting postcardiotomy cardiogenic shock (PCCS) in patients with poor left ventricular (LV) function undergoing cardiac surgery.</p><p><strong>Methods: </strong>From the Society of Thoracic Surgeons Adult Cardiac Database, 11,493 patients with LV ejection fraction ≤35% underwent isolated on-pump surgery from 2018 through 2019, of whom 3428 experienced PCCS. In total, 68 preoperative clinical variables were considered in machine-learning algorithms trained and optimized using scikit-learn software.</p><p><strong>Results: </strong>Compared with patients with ideal recovery, those that did were younger (65 vs 67 years), more likely female, Black, with low LV ejection fraction (26.5 vs 28.9%), previous myocardial infarction, chronic lung disease, diabetes, reoperation, or advanced heart failure. Among those with PCCS versus ideal recovery, operative mortality was 27% (925/3428) versus 0.1% (5/8065). PCCS occurred more often after coronary artery bypass grafting with concomitant mitral valve repair or after longer perfusion and clamp times. Reliable preoperative PCCS predictors were more advanced cardiac, liver, and renal failure; frailty; and greater white cell count. Out of sample test set receiver operating curve achieved an area under the curve of 0.74 with acceptable calibration Hosmer-Lemeshow statistic χ<sup>2</sup> = 1.33, <i>P</i> = .25.</p><p><strong>Conclusions: </strong>In patients with severe LV dysfunction undergoing cardiac surgery, risk of PCCS is elevated by preoperative failure of other organ systems and complexity of the planned operation that prolongs myocardial ischemia and cardiopulmonary bypass. This risk calculator could serve as an important tool to preoperatively identify patients in need of advanced levels of support.</p>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"272-285"},"PeriodicalIF":0.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: Is posterior pericardiotomy dangerous? Not based on evidence. 评论:后心包切开术危险吗?不是基于证据。
Pub Date : 2024-10-09 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.004
Giovanni Jr Soletti, Antonino Di Franco, Mario Gaudino
{"title":"Commentary: Is posterior pericardiotomy dangerous? Not based on evidence.","authors":"Giovanni Jr Soletti, Antonino Di Franco, Mario Gaudino","doi":"10.1016/j.xjon.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.10.004","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"255-256"},"PeriodicalIF":0.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of Mongolia's first independent and sustainable minimally invasive general thoracic surgery program: A Mongolian-Canadian initiative. 建立蒙古第一个独立和可持续的微创普通胸外科项目:蒙古-加拿大倡议。
Pub Date : 2024-10-09 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.09.026
Azjargal Badamkhand, Roy A Hilzenrat, Ganzorig Baatar, Mergen Dugarsuren, Sharon R Y Ong, Ahmad S Ashrafi

Objective: The advent of video-assisted thoracoscopic surgery in Mongolia has faced funding and accessibility challenges, leading to languid adoption. A Mongolian-Canadian collaboration was inaugurated to support the development of a self-sustainable, self-governed minimally invasive thoracic surgery (MITS) program in Mongolia.

Methods: A multidisciplinary Canadian thoracic surgery team collaborated with the National Cancer Center of Mongolia Thoracic Surgery service from 2016 to 2023. The team engaged in patient rounds, MITS procedures, and service education. Program and patient outcomes were reviewed.

Results: Thirty-four patients underwent MITS procedures as part of the Mongolian-Canadian collaboration. Median age was 51 years (range, 16-76 years), and 41% (14 out of 34) were men. Lung, esophageal, and mediastinal procedures composed 50% (17 out of 34), 21% (7 out of 34), and 21% (7 out of 34) of procedures, respectively. Conversion rate, median operative time, and hospital length of stay were 0%, 172.5 minutes, and 8 days, respectively. The complication rate was 9% (3 out of 34) with 3% (1 out of 34) being Clavien-Dindo >3 requiring re-operation. Thirty-day mortality was 0%. Mongolia's thoracic surgery team progressed from surgical assists to primary operators and a self-governed program. In 2023, the National Cancer Center of Mongolia's thoracic surgery service independently conducted 72% (50 out of 69) of esophagectomies and 91% (48 out of 53) of pulmonary resections via minimally invasive technique compared with 0% in 2015.

Conclusions: The Mongolian-Canadian collaboration demonstrated successful transfer of MITS proficiency through global noncolonialist surgical partnership, consequentially shifting the national thoracic surgical paradigm. Continued collaboration will focus on sustainability and supporting local surgeons in regional dissemination of MITS proficiency with the aim of globalizing thoracic surgical excellence.

目的:视频胸腔镜手术在蒙古的出现面临资金和可及性的挑战,导致缓慢采用。一项蒙古-加拿大合作项目启动,以支持蒙古开展自我可持续、自我管理的微创胸外科项目。方法:2016 - 2023年,加拿大多学科胸外科团队与蒙古国家癌症中心胸外科服务中心合作。该团队进行了病人查房、MITS程序和服务教育。回顾了方案和患者结果。结果:34例患者接受了MITS手术,这是蒙加合作的一部分。中位年龄为51岁(范围16-76岁),41%(34人中14人)为男性。肺、食管和纵隔手术分别占50%(17 / 34)、21%(7 / 34)和21%(7 / 34)。转换率为0%,中位手术时间为172.5分钟,住院时间为8天。并发症发生率为9%(34例中有3例),其中3%(34例中有1例)为Clavien-Dindo bb3,需要再次手术。30天死亡率为0%。蒙古的胸外科团队从辅助手术发展到主要的操作者和一个自治的项目。2023年,蒙古国家癌症中心胸外科服务独立实施了72%(69例中有50例)的食管切除术和91%(53例中有48例)的肺切除术,而2015年这一比例为0%。结论:蒙古和加拿大的合作证明了通过全球非殖民外科合作伙伴关系成功地转移了MITS的熟练程度,从而改变了国家胸外科的模式。持续的合作将侧重于可持续性,并支持当地外科医生在区域内传播MITS的熟练程度,以实现胸外科卓越技术的全球化。
{"title":"Establishment of Mongolia's first independent and sustainable minimally invasive general thoracic surgery program: A Mongolian-Canadian initiative.","authors":"Azjargal Badamkhand, Roy A Hilzenrat, Ganzorig Baatar, Mergen Dugarsuren, Sharon R Y Ong, Ahmad S Ashrafi","doi":"10.1016/j.xjon.2024.09.026","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.09.026","url":null,"abstract":"<p><strong>Objective: </strong>The advent of video-assisted thoracoscopic surgery in Mongolia has faced funding and accessibility challenges, leading to languid adoption. A Mongolian-Canadian collaboration was inaugurated to support the development of a self-sustainable, self-governed minimally invasive thoracic surgery (MITS) program in Mongolia.</p><p><strong>Methods: </strong>A multidisciplinary Canadian thoracic surgery team collaborated with the National Cancer Center of Mongolia Thoracic Surgery service from 2016 to 2023. The team engaged in patient rounds, MITS procedures, and service education. Program and patient outcomes were reviewed.</p><p><strong>Results: </strong>Thirty-four patients underwent MITS procedures as part of the Mongolian-Canadian collaboration. Median age was 51 years (range, 16-76 years), and 41% (14 out of 34) were men. Lung, esophageal, and mediastinal procedures composed 50% (17 out of 34), 21% (7 out of 34), and 21% (7 out of 34) of procedures, respectively. Conversion rate, median operative time, and hospital length of stay were 0%, 172.5 minutes, and 8 days, respectively. The complication rate was 9% (3 out of 34) with 3% (1 out of 34) being Clavien-Dindo >3 requiring re-operation. Thirty-day mortality was 0%. Mongolia's thoracic surgery team progressed from surgical assists to primary operators and a self-governed program. In 2023, the National Cancer Center of Mongolia's thoracic surgery service independently conducted 72% (50 out of 69) of esophagectomies and 91% (48 out of 53) of pulmonary resections via minimally invasive technique compared with 0% in 2015.</p><p><strong>Conclusions: </strong>The Mongolian-Canadian collaboration demonstrated successful transfer of MITS proficiency through global noncolonialist surgical partnership, consequentially shifting the national thoracic surgical paradigm. Continued collaboration will focus on sustainability and supporting local surgeons in regional dissemination of MITS proficiency with the aim of globalizing thoracic surgical excellence.</p>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"521-527"},"PeriodicalIF":0.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sternotomy or thoracotomy for neonatal repair of coarctation of the aorta with aortic arch hypoplasia. 胸骨或开胸术治疗新生儿主动脉缩窄伴主动脉弓发育不全。
Pub Date : 2024-10-05 eCollection Date: 2024-12-01 DOI: 10.1016/j.xjon.2024.10.001
Peter Chiu, Addison Gearhart, Ajami Gikandi, Supreet Marathe, Margaret Holland, Shinichi Goto, Sunil J Ghelani, Aditya K Kaza

Objective: For neonatal repair of coarctation of the aorta, patients may either undergo thoracotomy with extended end-to-end anastomosis or sternotomy for aortic arch reconstruction with cardiopulmonary bypass. The objective of this study was to evaluate the comparative effectiveness of the 2 approaches in patients with arch hypoplasia.

Methods: This is a single-center retrospective cohort study from July 2005 through May 2022 of patients who underwent neonatal repair for isolated coarctation of the aorta with additional arch hypoplasia. Inverse probability of treatment weighting is a statistical method for creating comparable pseudopopulations and was used to account for baseline differences in population. The primary outcome was aortic reintervention, and secondary outcomes were vocal cord dysfunction, length of stay, chylothorax, and phrenic nerve palsy.

Results: There were 130 patients who met inclusion criteria. After weighting, the interaction between distal transverse arch size and operative approach (sternotomy vs thoracotomy) was statistically significant, P < .05 for interaction. Among patients with a distal arch z-score <-3.5, patients undergoing thoracotomy with extended end-to-end anastomosis had an increased hazard for reintervention. Sternotomy was associated with an increased length of stay in the intensive care unit by 4.7 days, P < .001, and odds of vocal cord dysfunction were also greater, odds ratio 7.1 (95% confidence interval, 1.66 to 41.26; P = .01).

Conclusions: Among patients with a distal arch z-score smaller than -3.5, the hazard of reintervention was increased for patients undergoing thoracotomy with extended end-to-end anastomosis. However, length of stay and risk of vocal cord paresis was reduced in patients undergoing thoracotomy.

目的:新生儿主动脉缩窄的修复,可采用开胸端端延伸吻合或胸骨开胸行体外循环主动脉弓重建。本研究的目的是评价两种入路治疗弓发育不全患者的比较效果。方法:这是一项2005年7月至2022年5月的单中心回顾性队列研究,研究对象是因孤立性主动脉缩窄合并弓发育不全而接受新生儿修复术的患者。治疗加权逆概率是一种创建可比较伪种群的统计方法,用于解释种群的基线差异。主要结局是主动脉再次介入治疗,次要结局是声带功能障碍、住院时间、乳糜胸和膈神经麻痹。结果:130例患者符合纳入标准。加权后,远端横弓大小与手术入路(胸骨切开与开胸切开)的相互作用有统计学意义,P P P = 0.01)。结论:在远端弓z-评分小于-3.5的患者中,开胸端端延伸吻合术患者再干预的风险增加。然而,在接受开胸手术的患者中,住院时间和声带麻痹的风险降低了。
{"title":"Sternotomy or thoracotomy for neonatal repair of coarctation of the aorta with aortic arch hypoplasia.","authors":"Peter Chiu, Addison Gearhart, Ajami Gikandi, Supreet Marathe, Margaret Holland, Shinichi Goto, Sunil J Ghelani, Aditya K Kaza","doi":"10.1016/j.xjon.2024.10.001","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.10.001","url":null,"abstract":"<p><strong>Objective: </strong>For neonatal repair of coarctation of the aorta, patients may either undergo thoracotomy with extended end-to-end anastomosis or sternotomy for aortic arch reconstruction with cardiopulmonary bypass. The objective of this study was to evaluate the comparative effectiveness of the 2 approaches in patients with arch hypoplasia.</p><p><strong>Methods: </strong>This is a single-center retrospective cohort study from July 2005 through May 2022 of patients who underwent neonatal repair for isolated coarctation of the aorta with additional arch hypoplasia. Inverse probability of treatment weighting is a statistical method for creating comparable pseudopopulations and was used to account for baseline differences in population. The primary outcome was aortic reintervention, and secondary outcomes were vocal cord dysfunction, length of stay, chylothorax, and phrenic nerve palsy.</p><p><strong>Results: </strong>There were 130 patients who met inclusion criteria. After weighting, the interaction between distal transverse arch size and operative approach (sternotomy vs thoracotomy) was statistically significant, <i>P</i> < .05 for interaction. Among patients with a distal arch z-score <-3.5, patients undergoing thoracotomy with extended end-to-end anastomosis had an increased hazard for reintervention. Sternotomy was associated with an increased length of stay in the intensive care unit by 4.7 days, <i>P</i> < .001, and odds of vocal cord dysfunction were also greater, odds ratio 7.1 (95% confidence interval, 1.66 to 41.26; <i>P</i> = .01).</p><p><strong>Conclusions: </strong>Among patients with a distal arch z-score smaller than -3.5, the hazard of reintervention was increased for patients undergoing thoracotomy with extended end-to-end anastomosis. However, length of stay and risk of vocal cord paresis was reduced in patients undergoing thoracotomy.</p>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"22 ","pages":"386-394"},"PeriodicalIF":0.0,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic-assisted coronary artery bypass grafting simplified: Lessons learned after 20 years 简化机器人辅助冠状动脉旁路移植术:20 年后的经验教训
Pub Date : 2024-10-01 DOI: 10.1016/j.xjon.2024.07.023
Mark Lutz BA, Zhandong Zhou MD, Ahmad Nazem MD, G. Randall Green MD, JD, MBA, Anton Cherney MD, Karikehalli Dilip MD, Charles J. Lutz MD
{"title":"Robotic-assisted coronary artery bypass grafting simplified: Lessons learned after 20 years","authors":"Mark Lutz BA,&nbsp;Zhandong Zhou MD,&nbsp;Ahmad Nazem MD,&nbsp;G. Randall Green MD, JD, MBA,&nbsp;Anton Cherney MD,&nbsp;Karikehalli Dilip MD,&nbsp;Charles J. Lutz MD","doi":"10.1016/j.xjon.2024.07.023","DOIUrl":"10.1016/j.xjon.2024.07.023","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"21 ","pages":"Pages 119-121"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142553535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative pathways in revascularization for non-ST elevation acute coronary syndrome 非ST段抬高急性冠状动脉综合征血管重建的创新途径
Pub Date : 2024-10-01 DOI: 10.1016/j.xjon.2024.07.017
FNU Venjhraj MBBS , Vikram Singh Medical Technologist , Ashvin Kumar MBBS , Aiman Salam Shaikh MBBS
{"title":"Innovative pathways in revascularization for non-ST elevation acute coronary syndrome","authors":"FNU Venjhraj MBBS ,&nbsp;Vikram Singh Medical Technologist ,&nbsp;Ashvin Kumar MBBS ,&nbsp;Aiman Salam Shaikh MBBS","doi":"10.1016/j.xjon.2024.07.017","DOIUrl":"10.1016/j.xjon.2024.07.017","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"21 ","pages":"Page 122"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142553536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support? 使用 Impella 5.5 支持系统的患者出现不良预后是否存在特定病因的风险因素?
Pub Date : 2024-10-01 DOI: 10.1016/j.xjon.2024.04.014

Objectives

To identify possible etiology-specific differences in preoperative risk factors for major adverse events during Impella 5.5 support in patients with ischemic (ICM) and nonischemic cardiomyopathy (NICM).

Methods

From October 2019 to January 2023, 228 Impella 5.5 devices were inserted at our institution. Patients were stratified into ICM (n = 124) and NICM (n = 104) cohorts. The primary outcome was a composite of death/stroke/new-onset dialysis while actively receiving Impella 5.5 support. Random forests identified preoperative factors predictive of the primary outcome separately for each cohort, with ranking by variable importance.

Results

The primary outcome occurred in 42 (34%) patients with ICM and 35 (34%) patients with NICM. Twenty-one (17%) patients with ICM and 21 (20%) patients with NICM died on Impella 5.5; stroke occurred in 12 (9.7%) patients with ICM and 3 (2.9%) patients with NICM, and new-onset dialysis was initiated in 23 (19%) patients with ICM and 24 (23%) patients with NICM while actively receiving Impella 5.5 support. Risk factors reflecting systemic and myocardial cellular injury, end-organ and cardiopulmonary failure, right ventricular dysfunction, and smaller left ventricular dimensions were most predictive of adverse outcomes in both cohorts. Indications for Impella 5.5 and device strategy (bridge to recovery, advanced therapies, or decision) were not top risk factors in either cohort.

Conclusions

Risk factors related to preoperative stability, right ventricular dysfunction, and left ventricular size were more predictive of adverse outcomes while actively receiving Impella 5.5 support than indication or device strategy. These factors could help identify high-risk patients who may benefit from additional tailored management to reduce their risk for these impactful adverse outcomes while on Impella 5.5 support.
目的确定缺血性(ICM)和非缺血性心肌病(NICM)患者在接受 Impella 5.5 支持期间发生主要不良事件的术前风险因素可能存在的病因特异性差异。方法从 2019 年 10 月到 2023 年 1 月,我院共植入了 228 台 Impella 5.5 装置。患者被分为 ICM 组(124 人)和 NICM 组(104 人)。主要结果是在积极接受Impella 5.5支持期间死亡/中风/新发透析的复合结果。随机森林分别确定了每个队列中预测主要结局的术前因素,并按变量重要性进行了排序。结果42(34%)名 ICM 患者和 35(34%)名 NICM 患者出现了主要结局。21 名 ICM 患者(17%)和 21 名 NICM 患者(20%)在接受 Impella 5.5 支持期间死亡;12 名 ICM 患者(9.7%)和 3 名 NICM 患者(2.9%)发生中风;23 名 ICM 患者(19%)和 24 名 NICM 患者(23%)在积极接受 Impella 5.5 支持期间开始新发透析。反映全身和心肌细胞损伤、内脏器官和心肺功能衰竭、右心室功能障碍和左心室尺寸较小的风险因素最能预测这两组患者的不良预后。结论与术前稳定性、右心室功能障碍和左心室尺寸相关的风险因素比适应症或设备策略更能预测积极接受Impella 5.5支持时的不良预后。这些因素有助于识别高风险患者,这些患者可能受益于额外的定制化管理,以降低他们在接受Impella 5.5支持时出现这些有影响的不良后果的风险。
{"title":"Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?","authors":"","doi":"10.1016/j.xjon.2024.04.014","DOIUrl":"10.1016/j.xjon.2024.04.014","url":null,"abstract":"<div><h3>Objectives</h3><div>To identify possible etiology-specific differences in preoperative risk factors for major adverse events during Impella 5.5 support in patients with ischemic (ICM) and nonischemic cardiomyopathy (NICM).</div></div><div><h3>Methods</h3><div>From October 2019 to January 2023, 228 Impella 5.5 devices were inserted at our institution. Patients were stratified into ICM (n = 124) and NICM (n = 104) cohorts. The primary outcome was a composite of death/stroke/new-onset dialysis while actively receiving Impella 5.5 support. Random forests identified preoperative factors predictive of the primary outcome separately for each cohort, with ranking by variable importance.</div></div><div><h3>Results</h3><div>The primary outcome occurred in 42 (34%) patients with ICM and 35 (34%) patients with NICM. Twenty-one (17%) patients with ICM and 21 (20%) patients with NICM died on Impella 5.5; stroke occurred in 12 (9.7%) patients with ICM and 3 (2.9%) patients with NICM, and new-onset dialysis was initiated in 23 (19%) patients with ICM and 24 (23%) patients with NICM while actively receiving Impella 5.5 support. Risk factors reflecting systemic and myocardial cellular injury, end-organ and cardiopulmonary failure, right ventricular dysfunction, and smaller left ventricular dimensions were most predictive of adverse outcomes in both cohorts. Indications for Impella 5.5 and device strategy (bridge to recovery, advanced therapies, or decision) were not top risk factors in either cohort.</div></div><div><h3>Conclusions</h3><div>Risk factors related to preoperative stability, right ventricular dysfunction, and left ventricular size were more predictive of adverse outcomes while actively receiving Impella 5.5 support than indication or device strategy. These factors could help identify high-risk patients who may benefit from additional tailored management to reduce their risk for these impactful adverse outcomes while on Impella 5.5 support.</div></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"21 ","pages":"Pages 123-137"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140768468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JTCVS open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1